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Introduction
Pediatric uveitis is a blinding disease in 15-20 % of
cases. Juvenile idiopathic arthritis (JIA) is the most com-
mon disease associated with uveitis (JIAU).Biologics
have changed the treatment of uveitis in particular JIAU.
Objectives
To describe epidemiological, clinical, ophthalmologic
and therapeutic characteristic of non infectious pediatric
uveitis followed in our center.
Methods
We retrospectively collected data between 2004 and
2013 for children under 16 years of age followed for
non-infectious uveitis in the Department of Ophthalmol-
ogy and in Pediatric Rheumatology Unit of the Hospital of
Tours.
Results
Of 32 children included there were 62 % of females and
the mean age at diagnosis was 7.7 ± 3.4 years and 6.5 ±
3.8 years for JIAU. Ophthalmologic complications were
present at the diagnosis in 72% of patients. Uveitis was
unilateral in 56 % of cases and anterior in 75 % of cases.
At the time of the last follow-up 41% were idiopathic
uveitis and 41% JIAU. The number of inflammatory cells
in the uvea (Tyndall) was improved in 50 % of cases and
stabilized in 50 % of cases. One third of patients had pre-
sented new ophthalmologic complications. Uveitis was
recurrent in 84 % of cases and 75% of uveitis had
relapsed at least once. Local corticosteroid was always
used in combination with systemic treatment . Corti-
cotherapy was used in 41% of cases, and associated to
DMARDS (methotrexate) in 19% of patients. Anti-TNFa
(adalimumab) was used in 42% of patients and 54% of
JIAU. An improvement in the visual acuity of our cohort
was found (4/10 initially versus 6.3/10). In the subgroup
of JIAU (13 patients) visual acuity was modified from 4/
10 to 5/10 and 23% patients used the systemic associa-
tion;corticosteroid and methotrexate , 3 patients relapsed
under adalimumab.
Conclusion
The risk of visual impairment in child uveitis is important.
JIA is the main etiology.Biologics prescription have not
been validated yet. The lack of consensus on the therapeu-
tic strategy validate the need for a multidisciplinary colla-
boration between the ophthalmologist and the pediatric
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